Article info

Download PDFPDF

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models

Authors

Citation

Huseni M, Totpal K, Du C, et al
Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models

Publication history

  • First published November 6, 2014.
Online issue publication 
November 06, 2014

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.